NCT05154890 — Homocystinuria Due to Cystathionine Beta-Synthase Deficiency trial site landscape

Public-registry site landscape for NCT05154890, a Homocystinuria Due to Cystathionine Beta-Synthase Deficiency study sponsored by Aeglea Biotherapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05154890 (registry record)
Sponsor	Aeglea Biotherapeutics
Condition(s)	Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
Phase	PHASE1 / PHASE2
Listed sites	9
Site countries	United States, Australia, United Kingdom

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05154890 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.